Table 2 Comparison of 5-year survival rates taking disease stage into consideration
AIBCES | Non-AIBCES | p | |
|---|---|---|---|
Number of patients | 1343 | 792 | |
Time at risk (days) | 1985,832 | 10,55,612 | |
Death | 670 (50%) | 455 (57%) | |
5-year survival rate (%) | |||
All cStages | 52.8% | 45.70% | <0.01 |
cStage 0 | 87.5% | – | |
cStage I | 76.8% | 74.3% | 0.18 |
cStage II | 55.1% | 44.9% | <0.01 |
cStage III | 38.0% | 30.3% | <0.01 |
cStage IV | 28.2% | 18.3% | 0.06 |